futurehealth.com tirzepatide FuturHealth: GLP-1s + Meals = Better Results 02/27/2025 Cost of Tirzepatide for Medical

Fewer events in the placebo arm of SURMOUNT-1 compared with ONeil, STEP 1 and STEP 8 for total gastrointestinal AEs and nausea AEs suggest that the relative safety of tirzepatide versus liraglutide and semaglutide may be underestimated for these outcomes (see Supplementary Material Table S3)

Health and Medicine Division

Tirzepatide, the active ingredient of Mounjaro, is approved for weight loss under the brand name Zepbound

Metabolic alterations and systemic inflammation in overweight/obese children with obstructive sleep apnea

trials show ~1821% mean weight loss at 72 weeks

This dual-action mechanism has been shown in clinical studies to produce greater weight loss outcomes compared to single-pathway GLP-1 medications